Eterna Therapeutics's total assets for Q3 2025 were $6.17M, a decrease of -18.62% from the previous quarter. ERNA total liabilities were $2.60M for the fiscal quarter, a -17.13% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.